Biocatalysis cells and methods
Abstract
In one aspect, the invention provides a recombinant microbial cell modified to exhibit increased biosynthesis of a biosynthetic product compared to a wild-type control. In some cases, the biosynthetic product can be isocaproate; in other cases the biosynthetic product can be isovalerate. In another aspect, the invention provides methods of constructing such recombinant cells. In yet another aspect, the invention provides methods of using the cells to produce the biosynthetic product. In yet another aspect, the invention provides methods of harvesting organic acids from a fermentation culture.
Claims
exact text as granted — not AI-modified1 . A recombinant microbial cell modified to exhibit increased biosynthesis of isocaproate compared to a wild-type control.
2 . A recombinant microbial cell modified to exhibit increased biosynthesis of isovalerate compared to a wild-type control.
3 . The recombinant microbial cell of claim 1 wherein the microbial cell is a fungal cell.
4 - 5 . (canceled)
6 . The recombinant microbial cell of claim 1 wherein the microbial cell is a bacterial cell.
7 - 19 . (canceled)
20 . The recombinant microbial cell of claim 1 wherein the microbial cell is photosynthetic.
21 . The recombinant microbial cell of claim 1 wherein the microbial cell is cellulolytic.
22 . The recombinant cell of claim 1 wherein the increased biosynthesis of isocaproate compared to a wild-type control comprises an increase in 2-isopropylmalate synthase activity compared to a wild-type control, an increase in ketoleucine elongation activity compared to a wild-type control, an increase in ketoacid decarboxylase activity compared to a wild-type control, an increase in ketoacid decarboxylase selectivity toward a predetermined substrate compared to a wild-type control, or an increase in aldehyde dehydrogenase activity compared to a wild-type control.
23 - 25 . (canceled)
26 . The recombinant cell of claim 2 wherein the increased biosynthesis of isovalerate compared to a wild-type control comprises increased leucine biosynthesis compared to a wild-type control, increased decarboxylase activity compared to a wild-type control, increased aldehyde dehydrogenase activity compared to a wild-type control, or increased branched-chain ketoacid dehydrogenase activity compared to a wild-type control.
27 - 28 . (canceled)
29 . A method comprising:
incubating the recombinant cell of claim 1 in medium that comprises a carbon source under conditions effective for the recombinant cell to produce isocaproate, wherein the carbon source comprises one or more of: glucose, pyruvate, ketovaline, ketoleucine, ketohomoleucine, CO 2 , cellulose, xylose, sucrose, arabinose, or glycerol.
30 . A method comprising:
incubating the recombinant cell of claim 2 in medium that comprises a carbon source under conditions effective for the recombinant cell to produce isovalerate, wherein the carbon source comprises one or more of: glucose, pyruvate, ketovaline, ketoleucine, isopentanal, CO 2 , cellulose, xylose, sucrose, arabinose, or glycerol.
31 . A method comprising:
introducing into a host cell a heterologous polynucleotide encoding at least one polypeptide that catalyzes conversion of a carbon source to isocaproate, wherein the at least one polypeptide is operably linked to a promoter so that the modified host cell catalyzes conversion of the carbon source to isocaproate.
32 . The method of claim 31 wherein the carbon source comprises one or more of:
glucose, pyruvate, ketovaline, ketoleucine, ketohomoleucine, CO 2 , cellulose, xylose, sucrose, arabinose, or glycerol.
33 . A method comprising:
introducing into a host cell a heterologous polynucleotide encoding at least one polypeptide that catalyzes conversion of a carbon source to isovalerate, wherein the at least one polypeptide is operably linked to a promoter so that the modified host cell catalyzes conversion of the carbon source to isovalerate.
34 . The method of claim 33 wherein the carbon source comprises one or more of:
glucose, pyruvate, ketovaline, ketoleucine, isopentanal, CO 2 , cellulose, xylose, sucrose, arabinose, or glycerol.
35 . The method of claim 31 wherein the host cell is a fungal cell.
36 - 37 . (canceled)
38 . The method of claim 31 wherein the host cell is a bacterial cell.
39 - 51 . (canceled)
52 . The method of claim 31 wherein the host cell is photosynthetic.
53 . The method of claim 31 wherein the host cell is cellulolytic.
54 . A method of harvesting an organic acid from a fermentation broth, the method comprising:
adjusting the pH of the fermentation broth to about 3.0; adding an organic solvent to the fermentation broth, thereby producing an aqueous phase and a non-aqueous phase; and extracting the organic acid from the aqueous phase.
55 . The method of claim 54 wherein the organic solvent comprises hexane or oleyl alcohol.
56 . The recombinant microbial cell of claim 2 wherein the microbial cell is a fungal cell.
57 . The recombinant microbial cell of claim 2 wherein the microbial cell is a bacterial cell.
58 . The recombinant microbial cell of claim 2 wherein the microbial cell is photosynthetic.
59 . The recombinant microbial cell of claim 2 wherein the microbial cell is cellulolytic.
60 . The method of claim 33 wherein the host cell is a fungal cell.
61 . The method of claim 33 wherein the host cell is a bacterial cell.
62 . The method of claim 33 wherein the host cell is photosynthetic.
63 . The method of claim 33 wherein the host cell is cellulolytic.Join the waitlist — get patent alerts
Track US2014329275A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.